|
Volumn 49, Issue 11, 1999, Pages 905-911
|
Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189
a a a a a a a a a a |
Author keywords
5 4 2 (1 Indolyl)ethoxylphenylmethyl thiazolidine 2,4 dione; CAS 172647 53 9; DRF 2189, euglycemic activity, hypolipidemic activity; Insulin sensitizer
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 [4 [2 (1 INDOLYL)ETHOXY]BENZYL] 2,4 THIAZOLIDINEDIONE;
CHOLESTEROL;
GLUCOSE;
INDOLE DERIVATIVE;
LIPID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
TRIACYLGLYCEROL;
TROGLITAZONE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLUCOSE BLOOD LEVEL;
HYPOLIPEMIA;
LIPID BLOOD LEVEL;
MALE;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RAT;
SMOOTH MUSCLE RELAXATION;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 0032710611
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0031-1300525 Document Type: Article |
Times cited : (10)
|
References (23)
|